Effects of intravenous AICAR (5-aminoimidazole-4-carboximide riboside) administration on insulin signaling and resistance in premature baboons, Papio sp.
Premature baboons exhibit peripheral insulin resistance and impaired insulin signaling. 5' AMP-activated protein kinase (AMPK) activation improves insulin sensitivity by enhancing glucose uptake (via increased glucose transporter type 4 [GLUT4] translocation and activation of the extracellular...
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2018-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0208757 |
| _version_ | 1818938436628774912 |
|---|---|
| author | Cynthia L Blanco Amalia Gastaldelli Diana G Anzueto Lauryn A Winter Steven R Seidner Donald C McCurnin Hanyu Liang Martin A Javors Ralph A DeFronzo Nicolas Musi |
| author_facet | Cynthia L Blanco Amalia Gastaldelli Diana G Anzueto Lauryn A Winter Steven R Seidner Donald C McCurnin Hanyu Liang Martin A Javors Ralph A DeFronzo Nicolas Musi |
| author_sort | Cynthia L Blanco |
| collection | DOAJ |
| description | Premature baboons exhibit peripheral insulin resistance and impaired insulin signaling. 5' AMP-activated protein kinase (AMPK) activation improves insulin sensitivity by enhancing glucose uptake (via increased glucose transporter type 4 [GLUT4] translocation and activation of the extracellular signal-regulated kinase [ERK]/ atypical protein kinase C [aPKC] pathway), and increasing fatty acid oxidation (via inhibition of acetyl-CoA carboxylase 1 [ACC]), while downregulating gluconeogenesis (via induction of small heterodimer partner [SHP] and subsequent downregulation of the gluconeogenic enzymes: phosphoenolpyruvate carboxykinase [PEPCK], glucose 6-phosphatase [G6PASE], fructose- 1,6-bisphosphatase 1 [FBP1], and forkhead box protein 1 [FOXO1]). The purpose of this study was to investigate whether pharmacologic activation of AMPK with AICAR (5-aminoimidazole-4-carboximide riboside) administration improves peripheral insulin sensitivity in preterm baboons. 11 baboons were delivered prematurely at 125±2 days (67%) gestation. 5 animals were randomized to receive 5 days of continuous AICAR infusion at a dose of 0.5 mg·g-1·day-1. 6 animals were in the placebo group. Euglycemic hyperinsulinemic clamps were performed at 5±2 and 14±2 days of life. Key molecules potentially altered by AICAR (AMPK, GLUT4, ACC, PEPCK, G6PASE, FBP1, and FOXO1), and the insulin signaling molecules: insulin receptor (INSR), insulin receptor substrate 1 (IRS-1), protein kinase B (AKT), and peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC1α) were measured using RT-PCR and western blotting. AICAR infusion did not improve whole body insulin-stimulated glucose disposal in preterm baboons (12.8±2.4 vs 12.4±2.0 mg/(kg·min), p = 0.8, placebo vs AICAR). One animal developed complications during treatment. In skeletal muscle, AICAR infusion did not increase phosphorylation of ACC, AKT, or AMPK whereas it increased mRNA expression of ACACA (ACC), AKT, and PPARGC1A (PGC1α). In the liver, INSR, IRS1, G6PC3, AKT, PCK1, FOXO1, and FBP1 were unchanged, whereas PPARGC1A mRNA expression increased after AICAR infusion. This study provides evidence that AICAR does not improve insulin sensitivity in premature euglycemic baboons, and may have adverse effects. |
| first_indexed | 2024-12-20T06:07:50Z |
| format | Article |
| id | doaj.art-b9fd3a77c99d4a08afee98ab6f150563 |
| institution | Directory Open Access Journal |
| issn | 1932-6203 |
| language | English |
| last_indexed | 2024-12-20T06:07:50Z |
| publishDate | 2018-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj.art-b9fd3a77c99d4a08afee98ab6f1505632022-12-21T19:50:46ZengPublic Library of Science (PLoS)PLoS ONE1932-62032018-01-011312e020875710.1371/journal.pone.0208757Effects of intravenous AICAR (5-aminoimidazole-4-carboximide riboside) administration on insulin signaling and resistance in premature baboons, Papio sp.Cynthia L BlancoAmalia GastaldelliDiana G AnzuetoLauryn A WinterSteven R SeidnerDonald C McCurninHanyu LiangMartin A JavorsRalph A DeFronzoNicolas MusiPremature baboons exhibit peripheral insulin resistance and impaired insulin signaling. 5' AMP-activated protein kinase (AMPK) activation improves insulin sensitivity by enhancing glucose uptake (via increased glucose transporter type 4 [GLUT4] translocation and activation of the extracellular signal-regulated kinase [ERK]/ atypical protein kinase C [aPKC] pathway), and increasing fatty acid oxidation (via inhibition of acetyl-CoA carboxylase 1 [ACC]), while downregulating gluconeogenesis (via induction of small heterodimer partner [SHP] and subsequent downregulation of the gluconeogenic enzymes: phosphoenolpyruvate carboxykinase [PEPCK], glucose 6-phosphatase [G6PASE], fructose- 1,6-bisphosphatase 1 [FBP1], and forkhead box protein 1 [FOXO1]). The purpose of this study was to investigate whether pharmacologic activation of AMPK with AICAR (5-aminoimidazole-4-carboximide riboside) administration improves peripheral insulin sensitivity in preterm baboons. 11 baboons were delivered prematurely at 125±2 days (67%) gestation. 5 animals were randomized to receive 5 days of continuous AICAR infusion at a dose of 0.5 mg·g-1·day-1. 6 animals were in the placebo group. Euglycemic hyperinsulinemic clamps were performed at 5±2 and 14±2 days of life. Key molecules potentially altered by AICAR (AMPK, GLUT4, ACC, PEPCK, G6PASE, FBP1, and FOXO1), and the insulin signaling molecules: insulin receptor (INSR), insulin receptor substrate 1 (IRS-1), protein kinase B (AKT), and peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC1α) were measured using RT-PCR and western blotting. AICAR infusion did not improve whole body insulin-stimulated glucose disposal in preterm baboons (12.8±2.4 vs 12.4±2.0 mg/(kg·min), p = 0.8, placebo vs AICAR). One animal developed complications during treatment. In skeletal muscle, AICAR infusion did not increase phosphorylation of ACC, AKT, or AMPK whereas it increased mRNA expression of ACACA (ACC), AKT, and PPARGC1A (PGC1α). In the liver, INSR, IRS1, G6PC3, AKT, PCK1, FOXO1, and FBP1 were unchanged, whereas PPARGC1A mRNA expression increased after AICAR infusion. This study provides evidence that AICAR does not improve insulin sensitivity in premature euglycemic baboons, and may have adverse effects.https://doi.org/10.1371/journal.pone.0208757 |
| spellingShingle | Cynthia L Blanco Amalia Gastaldelli Diana G Anzueto Lauryn A Winter Steven R Seidner Donald C McCurnin Hanyu Liang Martin A Javors Ralph A DeFronzo Nicolas Musi Effects of intravenous AICAR (5-aminoimidazole-4-carboximide riboside) administration on insulin signaling and resistance in premature baboons, Papio sp. PLoS ONE |
| title | Effects of intravenous AICAR (5-aminoimidazole-4-carboximide riboside) administration on insulin signaling and resistance in premature baboons, Papio sp. |
| title_full | Effects of intravenous AICAR (5-aminoimidazole-4-carboximide riboside) administration on insulin signaling and resistance in premature baboons, Papio sp. |
| title_fullStr | Effects of intravenous AICAR (5-aminoimidazole-4-carboximide riboside) administration on insulin signaling and resistance in premature baboons, Papio sp. |
| title_full_unstemmed | Effects of intravenous AICAR (5-aminoimidazole-4-carboximide riboside) administration on insulin signaling and resistance in premature baboons, Papio sp. |
| title_short | Effects of intravenous AICAR (5-aminoimidazole-4-carboximide riboside) administration on insulin signaling and resistance in premature baboons, Papio sp. |
| title_sort | effects of intravenous aicar 5 aminoimidazole 4 carboximide riboside administration on insulin signaling and resistance in premature baboons papio sp |
| url | https://doi.org/10.1371/journal.pone.0208757 |
| work_keys_str_mv | AT cynthialblanco effectsofintravenousaicar5aminoimidazole4carboximideribosideadministrationoninsulinsignalingandresistanceinprematurebaboonspapiosp AT amaliagastaldelli effectsofintravenousaicar5aminoimidazole4carboximideribosideadministrationoninsulinsignalingandresistanceinprematurebaboonspapiosp AT dianaganzueto effectsofintravenousaicar5aminoimidazole4carboximideribosideadministrationoninsulinsignalingandresistanceinprematurebaboonspapiosp AT laurynawinter effectsofintravenousaicar5aminoimidazole4carboximideribosideadministrationoninsulinsignalingandresistanceinprematurebaboonspapiosp AT stevenrseidner effectsofintravenousaicar5aminoimidazole4carboximideribosideadministrationoninsulinsignalingandresistanceinprematurebaboonspapiosp AT donaldcmccurnin effectsofintravenousaicar5aminoimidazole4carboximideribosideadministrationoninsulinsignalingandresistanceinprematurebaboonspapiosp AT hanyuliang effectsofintravenousaicar5aminoimidazole4carboximideribosideadministrationoninsulinsignalingandresistanceinprematurebaboonspapiosp AT martinajavors effectsofintravenousaicar5aminoimidazole4carboximideribosideadministrationoninsulinsignalingandresistanceinprematurebaboonspapiosp AT ralphadefronzo effectsofintravenousaicar5aminoimidazole4carboximideribosideadministrationoninsulinsignalingandresistanceinprematurebaboonspapiosp AT nicolasmusi effectsofintravenousaicar5aminoimidazole4carboximideribosideadministrationoninsulinsignalingandresistanceinprematurebaboonspapiosp |